Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice

Table 3 Liver histological score of lean (control) and obese (high-fat diet) mice treated with pentoxifylline

	Control		HFD
	NT	PTX	NT	PTX
Macrosteatosis	0 (0-0)	0 (0-0)	2.0 (1-3)	2.0 (2-3)
Microsteatosis	0 (0-0)	0 (0-0)	1.8 (1-3)	1.3 (1-2)a
Hyperemia	0 (0-0)	0 (0-0)	0.8 (0-1)	0.3 (0-1)a
Inflammation	0 (0-0)	0 (0-0)	0.6 (0-1)	0.3 (0-1)c
Fibrosis	0 (0-0)	0 (0-0)	0 (0-0)	0 (0-0)

^aP = 0.06;

^cP < 0.05 vs the matched NT group. HFD: High-fat diet; NT: Non-treated; PTX: Pentoxifylline.